foxo4-dri vs gdf-11 HDAC3 represses Nrf2-GDF11 signaling to drive chondrocyte adipogenesis in temporomandibular joint osteoarthritis FOXO4-DRI | FOXO4/p53 Interaction Blocker
FOXO4 DRI FOXO4 p53 Interaction Blocker MedChemExpress Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age Related Cardiac Hypertrophy: Cell The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Structural basis for potency differences between GDF8 and GDF11 BMC Biology Springer Nature Link
Pay in 4 interest-free payments of $7.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




